Clinical Trials Directory

Trials / Unknown

UnknownNCT06135597

Immune Regulation in Chronic Aspergillus Infection After COVID-19 Infection

Role of Cellular Immune Regulation in Acute Exacerbation and Chronic Aspergillus Infection After COVID-19 Infection

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Taipei Veterans General Hospital, Taiwan · Other Government
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

This study aims to collect clinical cases and follow-up data from patients with chronic pulmonary aspergillosis, post-COVID-19 aspergillosis, and post-COVID-19 patients without aspergillosis. Using in vitro assays, we will measure the phagocytic function of neutrophils when stimulated by fungal hyphae, their ability to produce neutrophil extracellular traps (NETs), the expression of cell surface molecules at the time of enrollment, changes in cell surface molecule expression after stimulation with fungal hyphae, and the quantification of autoantibodies in the blood. This research will focus on the short-term (within 3 months), medium-term (6-12 months), and long-term (more than 12 months) changes in cell surface molecules and functions following infection.

Conditions

Interventions

TypeNameDescription
OTHERThis is a blood test without regarding to intervention nor diagnostic testsThis is a blood test without regarding to intervention nor diagnostic tests

Timeline

Start date
2023-03-23
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2023-11-18
Last updated
2023-11-18

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06135597. Inclusion in this directory is not an endorsement.